The accompanying notes are an integral part of the unaudited consolidated financial statements.
The accompanying notes are an integral part of the unaudited consolidated financial statements.
The accompanying notes are an integral part of the unaudited consolidated financial statements.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)
THREE MONTHS ENDED MARCH 31, 2017 AND 2016
NOTE 1 – DESCRIPTION OF BUSINESS
Organization
References in the notes to unaudited consolidated financial statements to “the Company”, “Terra Tech”, “we”, “us”, or “our” are intended to mean Terra Tech Corp., individually, or as the context requires, collectively with its subsidiaries on a consolidated basis.
Through MediFarm, LLC, a Nevada limited liability company (“MediFarm”), MediFarm I, LLC, a Nevada limited liability company (“MediFarm I”), and MediFarm II, LLC, a Nevada limited liability company (“MediFarm II”), subsidiaries in which the Company owns interests, the Company operates and/or plans to operate medical marijuana dispensary facilities, cultivation, and production facilities in Nevada. Through IVXX, LLC, a Nevada limited liability company (“IVXX LLC”), and IVXX, Inc., a California corporation (“IVXX Inc.”; together with IVXX LLC, “IVXX”), the Company’s wholly-owned subsidiary, the Company produces and sells a line of cannabis flowers, as well as a line of cannabis pure concentrates. Most recently, the Company formed another wholly-owned subsidiary, MediFarm I Real Estate, LLC, a Nevada limited liability company (“MediFarm I RE”), which owns the real property on which a medical marijuana dispensary will be constructed. The dispensary will be operated by MediFarm I. Through Black Oak Gallery, we operate a medical marijuana retail dispensary, a medical marijuana cultivation facility, and have a second medical marijuana cultivation facility in the early stages of construction, all in Oakland, California. The Company is a wholesale seller of locally grown hydroponic produce, herbs and floral products through its wholly-owned subsidiary, Edible Garden Corp., a Nevada corporation (“Edible Garden”).
On April 1, 2016, the Company acquired Black Oak Gallery, a California corporation (“Black Oak”). Black Oak operates a medical marijuana retail dispensary in Oakland, California under the name Blüm, pursuant to that certain Agreement and Plan of Merger, dated December 23, 2015 (the “Merger Agreement”), with Generic Merger Sub, Inc., a California corporation and our wholly-owned subsidiary (the “Merger Sub”), and Black Oak.
Since the Merger was completed on April 1, 2016, Black Oak’s financial results are not included in our unaudited consolidated financial statements for the three months ended March 31, 2016.
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the three months ended March 31, 2017 are not necessarily indicative of the results that may be expected for the year ending December 31, 2017.
The consolidated balance sheet at December 31, 2016 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. For further information, refer to the consolidated financial statements and footnotes thereto included in Terra Tech’s annual report on Form 10-K for the year ended December 31, 2016.
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(Continued)
Non-Controlling Interest
Non-controlling interest is shown as a component of shareholders’ equity on the consolidated balance sheets and the share of income (loss) attributable to non-controlling interest is shown as a component of income (loss) in the consolidated statements of operations.
Use of Estimates
The preparation of financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Inventory
We value our inventory at the lower of the actual cost of our inventory, as determined using the first-in, first-out method, or its current estimated net realizable value (“NRV”). ASU No. 2015-11,
“Inventory (Topic 330): Simplifying the Measurement of Inventory”,
defines NRV as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. We periodically review our physical inventory for excess, obsolete, and potentially impaired items and reserve accordingly. Our reserve estimate for excess and obsolete is based on expected future use. Our reserve estimates have historically been consistent with our actual experience as evidenced by actual sale or disposal of the goods.
Property, Equipment and Leasehold Improvements
Property, equipment and leasehold improvements are stated at cost less accumulated depreciation. Depreciation is calculated using the straight-line method over the estimated useful lives of the assets. The approximate useful lives for depreciation of our property, equipment and leasehold improvements are as follows: 32 years for buildings; three to eight years for furniture and equipment; and the shorter of the estimated useful life or the underlying lease term for leasehold improvements. Repairs and maintenance expenditures that do not extend the useful lives of related assets are expensed as incurred.
Goodwill
Goodwill is measured as the excess of consideration transferred and the net of the acquisition date fair value of assets acquired and liabilities assumed in a business acquisition. Goodwill is not amortized for accounting purposes.
We review the goodwill allocated to each of our reporting units for possible impairment annually on August 1 and whenever events or changes in circumstances indicate its carrying amount may not be recoverable. When assessing goodwill for impairment, we have the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, after assessing the totality of events or circumstances, we determine it is more likely than not that the fair value of a reporting unit is less than its carrying amount, then we perform a two-step impairment test. If we conclude otherwise, then no further action is taken. We also have the option to bypass the qualitative assessment and only perform a quantitative assessment, which is the first step of the two-step impairment test. In the two-step impairment test, we measure the recoverability of goodwill by comparing a reporting unit’s carrying amount, including goodwill, to the estimated fair value of the reporting unit.
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(Continued)
Intangibles
Intangible assets are stated at historical cost and amortized over their estimated useful lives. We use a straight-line method of amortization, unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined. The approximate useful lives for amortization of our intangible assets are as follows:
Customer Relationships
|
|
5 to 12 Years
|
Trade Names
|
|
2 to 8 Years
|
Dispensary License
|
|
14 Years
|
Patent
|
|
2 Years
|
We review intangible assets subject to amortization quarterly to determine if any adverse conditions exist or a change in circumstances has occurred that would indicate impairment or a change in the remaining useful life. Intangible assets that have indefinite useful lives are tested annually for impairment, and are tested for impairment more frequently if events and circumstances indicate that the asset might be impaired. An impairment loss is recognized to the extent that the carrying amount of the reporting unit exceeds its fair value.
Impairment of Long-Lived Assets
We have adopted paragraph 360-10-35-17 of FASB Accounting Standards Codification (“ASC”) for our long-lived assets. Our long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. We assess the recoverability of our long-lived assets by comparing the projected undiscounted net cash flows associated with the related long-lived asset or group of assets over their remaining estimated useful lives against their respective carrying amounts. Impairment, if any, is based on the excess of the carrying amount over the fair value of those assets. Fair value is generally determined using the assets expected future discounted cash flows or market value, if readily determinable. If long-lived assets are determined to be recoverable, but the newly determined remaining estimated useful lives are shorter than originally estimated, the net book values of the long-lived assets are depreciated over the newly determined remaining estimated useful lives.
Other Assets
Other assets are comprised primarily of security deposits for leased properties in California, Nevada and New Jersey. The deposits will be returned at the end of the lease term.
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(Continued)
Revenue Recognition
We recognize revenue in accordance with ASC 605,
“Revenue Recognition,”
by recognizing as revenue the fees we charge customers because persuasive evidence of an arrangement exists, the fees we charge are substantially fixed or determinable during the period that we provide the goods or services, we and our customers understand the specific nature and terms of the agreed upon transactions, and payment is made for the goods or services when they have been rendered.
Cannabis Dispensary, Cultivation and Production
We recognize revenue from manufacturing and distribution product sales and upon transfer of title and risk to the customer, which occurs either at shipping (F.O.B. terms) or upon sell through depending on the arrangement.
Revenue from our retail dispensaries is recognized net of discounts, rebates, promotional adjustments, price adjustments and returns, and net of taxes collected from customers that are remitted to governmental authorities, with the collected taxes recorded as current liabilities until remitted to the relevant government authority. Revenue is recorded upon transfer of title and risk to the customer which occurs at the time customers take delivery of our products at our retail dispensaries. Upon purchase, we have no further performance obligations and collection is assured as sales are paid for at time of purchase.
Revenue related to the sale of consignment inventory is not recognized until the product is pulled from inventory and sold directly to end-customers. We recognize revenue from the sale of consignment inventory on a gross basis, as we have determined that: 1) we are the primary obligor to the customer; 2) we have latitude in establishing the sales prices and profit margins of our products; 3) we have discretion in selecting our suppliers; 4) we are responsible for loss or damage to consigned inventory; and 5) our customer validation process performs an important part of the process of providing such products to authorized customers. We believe that these factors outweigh the fact that we do not have title to the consigned inventory prior to its sale.
Herbs and Produce Products
We recognize revenue from products grown in our greenhouses and sold net of discounts, rebates, promotional adjustments, price adjustments, and estimated returns and upon transfer of title and risk to the customer, which occurs at shipping (F.O.B. terms). Upon shipment, we have no further performance obligations, selling price is fixed, and collection is reasonably assured.
Cost of Goods Sold
Cannabis Dispensary, Cultivation and Production
Cost of goods sold includes the costs directly attributable to product sales and includes amounts paid for finished goods, such as flower, edibles, and concentrates, as well as packaging and other supplies, fees for services and processing, other expenses for services, and allocated overhead. Overhead expenses include allocations of rent, administrative salaries, utilities, and related costs. It also includes the cost incurred in producing the oils, waxes, shatters, and clears sold by IVXX.
Herbs and Produce Products
Cost of goods sold are for the plants grown, packaging, other supplies and in addition to purchased plants which are sold into the retail marketplace by Edible Garden. Other expenses include freight, allocations of rent, utilities and repairs and maintenance.
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(Continued)
Stock-Based Compensation
The Company accounts for its stock-based awards in accordance with ASC subtopic 718-10,
“Compensation,”
which requires fair value measurement on the grant date and recognition of compensation expense for all share-based payment awards made to employees and directors, including restricted stock awards. For stock options, the Company estimates the fair value using a closed option valuation (Black-Scholes) model. The fair value of restricted stock awards is based upon the quoted market price of the common shares on the date of grant. The fair value is then expensed over the requisite service periods of the awards, net of estimated forfeitures, which is generally the performance period and the related amount is recognized in the consolidated statements of operations.
Warrants
ASC 815-40,
“Contracts in Entity’s Own Equity”
(“ASC 815-40”), requires freestanding contracts that are settled in a company’s own stock, including common stock warrants, to be designated as an equity instrument, asset or a liability. Under the provisions of ASC 815-40, a contract designated as an asset or a liability must be carried at fair value on a company’s balance sheet, with any changes in fair value recorded in the company’s results of operations. A contract designated as an equity instrument must be included within equity, and no fair value adjustments are required from period to period.
ASC 815,
“Derivatives and Hedging”
(“ASC 815”) requires all derivatives to be recorded on the balance sheet at fair value. Furthermore, ASC 815 precludes contracts issued or held by a reporting entity that are both (1) indexed to its own stock and (2) classified as stockholders’ equity in its statement of financial position from being treated as derivative instruments.
Research and Development
Research and development costs are expensed as incurred.
Income Taxes
We provide for income taxes based on enacted tax law and statutory tax rates at which items of income and expense are expected to be settled in our income tax return. Certain items of revenue and expense are reported for Federal income tax purposes in different periods than for financial reporting purposes, thereby resulting in deferred income taxes. Deferred taxes are also recognized for operating losses that are available to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. We have incurred net operating losses for financial-reporting and tax-reporting purposes. At March 31, 2017 and December 31, 2016, such net operating losses were offset entirely by a valuation allowance.
The Company recognizes uncertain tax positions based on a benefit recognition model. Provided that the tax position is deemed more likely than not of being sustained, the Company recognizes the largest amount of tax benefit that is greater than 50% likely of being ultimately realized upon settlement. The tax position is derecognized when it is no longer more likely than not of being sustained. The Company classifies income tax related interest and penalties as interest expense and selling, general and administrative expense, respectively, on the consolidated statements of operations.
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(Continued)
Loss Per Common Share
Net loss per share is computed in accordance with the provisions of ASC 260,
“Earnings Per Share,”
by dividing net loss by the weighted-average shares of common stock outstanding during the period. During a loss period, the effect of the potential exercise of stock options, warrants, convertible preferred stock, and convertible debt are not considered in the diluted loss per share calculation since the effect would be anti-dilutive. The results of operations were a net loss for the three months ended March 31, 2017 and 2016. Therefore, the basic and diluted weighted-average shares of common stock outstanding were the same for both periods.
Fair Value of Financial Instruments
We define fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities which are required to be recorded at fair value, we consider the principal or most advantageous market in which we would transact and the market-based risk measurements or assumptions that market participants would use in pricing the asset or liability, such as risks inherent in valuation techniques, transfer restrictions and credit risk. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:
Level 1 –
Quoted prices in active markets for identical assets or liabilities.
Level 2 –
Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3 –
Inputs that are generally unobservable and typically reflect management’s estimate of assumptions that market participants would use in pricing the asset or liability.
In accordance with the fair value accounting requirements, companies may choose to measure eligible financial instruments and certain other items at fair value. We have not elected the fair value option for any eligible financial instruments.
Recently Issued Accounting Standards
FASB ASU 2017-04 (Topic 350), “Intangibles - Goodwill and Others”
– Issued in January 2017, ASU 2017-04 simplifies how an entity is required to test goodwill for impairment by eliminating Step 2 from the goodwill impairment test. Step 2 measures a goodwill impairment loss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount of that goodwill. ASU 2017-04 is effective for annual periods beginning after December 15, 2019 including interim periods within those periods. We are currently evaluating the effect that ASU 2017-04 will have on our consolidated financial statements and related disclosures.
NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(Continued)
FASB ASU No. 2016-02 (Topic 842), “Leases”
– Issued in February 2016, ASU No. 2016-02 will require entities to recognize right-of-use assets and lease liabilities on the balance sheet for the rights and obligations created by all leases, including operating leases, with terms of more than 12 months. The new standard also requires additional disclosures on the amount, timing, and uncertainty of cash flows arising from leases. These disclosures include qualitative and quantitative information. The new standard will be effective for the Company on January 1, 2019. Early adoption is permitted. The Company is in the process of evaluating the impact the adoption of this standard will have on its consolidated financial statements and related disclosures.
FASB ASU No. 2014-09 (Topic 606), “Revenue from Contracts with Customers”
– Issued in May 2014, ASU 2014-09 will require an entity to recognize revenue when it transfers promised goods or services to customers using a five-step model that requires entities to exercise judgment when considering the terms of the contracts. In August 2015, the FASB issued ASU No. 2015-14,
“Revenue from Contracts with Customers (Topic 606): Deferral of the Effective Date”
. This amendment defers the effective date of ASU 2014-09 by one year. In March 2016, the FASB issued ASU 2016- 08,
“Principal versus Agent Considerations (Reporting Gross versus Net),”
which amends the principal versus agent guidance and clarifies that the analysis must focus on whether the entity has control of the goods or services before they are transferred to the customer. In addition, the FASB issued ASU Nos. 2016-20,
“Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers”
and 2016-12,
“Narrow-Scope Improvements and Practical Expedients”
, both of which provide additional clarification of certain provisions in Topic 606. These Accounting Standards Codification (“ASC”) updates are effective for annual reporting periods beginning after December 15, 2017, but early adoption is permitted. Early adoption is permitted only as of annual reporting periods after December 15, 2016. The standard permits the use of either the retrospective or retrospectively with the cumulative effect transition method. We are currently in the process of evaluating all revenue streams, accounting policies, practices and reporting to identify and understand any impact on our consolidated financial statements.
NOTE 3 – CONCENTRATIONS OF BUSINESS AND CREDIT RISK
The Company maintains cash balances in several financial institutions that are insured by the Federal Deposit Insurance Corporation up to certain federal limitations. At times, the Company’s cash balance exceeds these federal limitations.
The Company provides credit in the normal course of business to customers located throughout the U.S. The Company performs ongoing credit evaluations of its customers and maintains allowances for doubtful accounts based on factors surrounding the credit risk of specific customers, historical trends, and other information.
NOTE 4 – INVENTORY
Raw materials consist of Edible Garden’s herb product lines and IVXX’s line of cannabis pure concentrates. Work-in-progress consists of live plants grown for Edible Garden’s herb product lines, live plants grown at Black Oak, and IVXX’s line of cannabis pure concentrates. Finished goods consists of IVXX’s line of cannabis packaged products to be sold into dispensaries, and Edible Gardens products to be sold via food, drug, and mass channels.
Cost of goods sold is calculated using the average costing method. The Company reviews its inventory periodically to determine net realizable value. The Company writes down inventory, if required, based on forecasted demand. These factors are impacted by market and economic conditions, new products introductions, and require estimates that may include uncertain elements.
NOTE 4 – INVENTORY
(Continued)
As of March 31, 2017 and December 31, 2016, inventory consisted of the following:
|
|
March 31,
2017
|
|
|
December 31,
2016
|
|
|
|
|
|
|
|
|
Raw Materials
|
|
$
|
453,442
|
|
|
$
|
486,119
|
|
Work-in-Progress
|
|
|
740,877
|
|
|
|
570,145
|
|
Finished Goods
|
|
|
923,538
|
|
|
|
853,066
|
|
|
|
|
|
|
|
|
|
|
Total Inventory
|
|
$
|
2,117,857
|
|
|
$
|
1,909,330
|
|
NOTE 5 – PROPERTY, EQUIPMENT AND LEASEHOLD IMPROVEMENTS
As of March 31, 2017 and December 31, 2016, property, equipment and leasehold improvements at cost, less accumulated depreciation, consisted of the following:
|
|
March 31,
2017
|
|
|
December 31,
2016
|
|
|
|
|
|
|
|
|
Land and Building
|
|
$
|
1,454,124
|
|
|
$
|
1,454,124
|
|
Furniture and Equipment
|
|
|
3,326,103
|
|
|
|
3,141,244
|
|
Computer Hardware and Software
|
|
|
435,093
|
|
|
|
396,479
|
|
Leasehold Improvements
|
|
|
8,328,059
|
|
|
|
8,027,792
|
|
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
13,543,379
|
|
|
|
13,019,639
|
|
Less Accumulated Depreciation
|
|
|
(3,017,948
|
)
|
|
|
(2,554,875
|
)
|
|
|
|
|
|
|
|
|
|
Property, Equipment and Leasehold Improvements, Net
|
|
$
|
10,525,431
|
|
|
$
|
10,464,764
|
|
Depreciation expense related to property, equipment and leasehold improvements for the three months ended March 31, 2017 and 2016 was $463,073 and $150,729, respectively.
NOTE 6 – INTANGIBLE ASSETS
As of March 31, 2017 and December 31, 2016, intangible assets consisted of the following:
|
|
|
|
|
March 31, 2017
|
|
|
December 31, 2016
|
|
|
|
Estimated Useful Life in Years
|
|
|
Gross
Carrying Amount
|
|
|
Accumulated Amortization
|
|
|
Net
Carrying
Value
|
|
|
Gross
Carrying Amount
|
|
|
Accumulated Amortization
|
|
|
Net
Carrying
Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortized Intangible Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Customer Relationships
|
|
5 to 12
|
|
|
$
|
8,960,700
|
|
|
$
|
(999,744
|
)
|
|
$
|
7,960,956
|
|
|
$
|
8,960,700
|
|
|
$
|
(780,960
|
)
|
|
$
|
8,179,740
|
|
Trade Brands and Patent
|
|
2 to 8
|
|
|
|
498,598
|
|
|
|
(118,409
|
)
|
|
|
380,189
|
|
|
|
498,598
|
|
|
|
(91,061
|
)
|
|
|
407,537
|
|
Dispensary License
|
|
14
|
|
|
|
10,270,000
|
|
|
|
(733,572
|
)
|
|
|
9,536,428
|
|
|
|
10,270,000
|
|
|
|
(550,179
|
)
|
|
|
9,719,821
|
|
Total Amortized Intangible Assets
|
|
|
|
|
|
19,729,298
|
|
|
|
(1,851,725
|
)
|
|
|
17,877,573
|
|
|
|
19,729,298
|
|
|
|
(1,422,200
|
)
|
|
|
18,307,098
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unamortized Intangible Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trade Name
|
|
Indefinite
|
|
|
|
5,320,000
|
|
|
|
–
|
|
|
|
5,320,000
|
|
|
|
5,320,000
|
|
|
|
–
|
|
|
|
5,320,000
|
|
Total Unamortized Intangible Assets
|
|
|
|
|
|
5,320,000
|
|
|
|
–
|
|
|
|
5,320,000
|
|
|
|
5,320,000
|
|
|
|
–
|
|
|
|
5,320,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Intangible Assets
|
|
|
|
|
$
|
25,049,298
|
|
|
$
|
(1,851,725
|
)
|
|
$
|
23,197,573
|
|
|
$
|
25,049,298
|
|
|
$
|
(1,422,200
|
)
|
|
$
|
23,627,098
|
|
Intangible assets with finite lives are amortized over their estimated useful lives. We recorded amortization expense of $429,525 and $10,620 for the three months ended March 31, 2017 and 2016, respectively.
NOTE 7 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES
As of March 31, 2017 and December 31, 2016, accounts payable and accrued expenses consisted of the following:
|
|
March 31,
2017
|
|
|
December 31,
2016
|
|
|
|
|
|
|
|
|
Accounts Payable
|
|
$
|
2,155,895
|
|
|
$
|
1,986,907
|
|
Sales Tax Payable
|
|
|
1,008,479
|
|
|
|
122,470
|
|
Accrued Interest Payable
|
|
|
124,827
|
|
|
|
96,633
|
|
Accrued Expenses
|
|
|
403,128
|
|
|
|
211,390
|
|
|
|
|
|
|
|
|
|
|
Total Accounts Payable and Accrued Expenses
|
|
$
|
3,692,329
|
|
|
$
|
2,417,400
|
|
NOTE 8 – NOTES PAYABLE
As of March 31, 2017 and December 31, 2016, notes payable consisted of the following:
|
|
March 31,
2017
|
|
|
December 31,
2016
|
|
|
|
|
|
|
|
|
Unsecured promissory demand notes issued to an accredited investor, which bear interest at a rate of 4% per annum. Holder may elect to convert into common stock at $0.75 per share.
|
|
$
|
5,000
|
|
|
$
|
64,324
|
|
Convertible promissory note dated December 14, 2015, issued to accredited investors, which matured December 13, 2016 and bears interest at a rate of 12% per annum. The holder of the note extended the maturity to December 13, 2017. The conversion price is $0.1211, subject to adjustment.
|
|
|
500,000
|
|
|
|
500,000
|
|
Senior convertible promissory note dated October 28, 2016, issued to accredited investors, which matures April 28, 2018 and bears interest at a rate of 1% per annum. The conversion price is 90% of the average of the lowest three (3) VWAPs for the five (5) consecutive trading days prior to the conversion date.
|
|
|
–
|
|
|
|
102,582
|
|
Senior convertible promissory note dated November 1, 2016, issued to accredited investors, which matures May 1, 2018 and bears interest at a rate of 12% per annum. The conversion price is $0.35, subject to adjustment.
|
|
|
53,539
|
|
|
|
31,615
|
|
Senior convertible promissory note dated December 16, 2016, issued to accredited investors, which matures June 16, 2018 and bears interest at a rate of 12% per annum. The conversion price is $0.27, subject to adjustment.
|
|
|
743,841
|
|
|
|
1,220,155
|
|
Senior convertible promissory note dated February 23, 2017, issued to accredited investors, which matures August 22, 2018 and bears interest at a rate of 12% per annum. The conversion price is $0.25, subject to adjustment.
|
|
|
908,998
|
|
|
|
–
|
|
|
|
|
|
|
|
|
|
|
Total Debt
|
|
|
2,211,378
|
|
|
|
1,918,676
|
|
|
|
|
|
|
|
|
|
|
Less Short-Term Portion
|
|
|
505,000
|
|
|
|
564,324
|
|
|
|
|
|
|
|
|
|
|
Long-Term Portion
|
|
$
|
1,706,378
|
|
|
$
|
1,354,352
|
|
As of March 31, 2017 and December 31, 2016, total debt was $2,211,378 and $1,918,676, respectively, which included unamortized debt discount of $3,443,622 and $4,295,648, respectively. The senior secured promissory notes are secured by shares of common stock. There was accrued interest payable of $124,827 and $96,633 as of March 31, 2017 and December 31, 2016, respectively.
Securities Purchase Agreement Dated February 22, 2017 and 12% Senior Convertible Promissory Note Due August 22, 2018
On February 22, 2017, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with an accredited investor (the “Purchaser”) pursuant to which the Company sold to the Purchaser a 12% Senior Convertible Promissory Note due August 22, 2018 (the “Note”) in the principal amount of $3,000,000 for a purchase price of $3,000,000 (the “Offering”). There were no fees or expenses deducted from the net proceeds received by the Company in the Offering. The Note and the shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) issuable upon conversion of the Note (the “Conversion Shares”) are collectively referred to herein as the “Securities.”
NOTE 8 – NOTES PAYABLE
(Continued)
All principal and interest due and owing under the Note is convertible into shares of Common Stock at any time at the election of the holder at a conversion price per share equal to the lower of (i) $0.2495 or (ii) 85% of the lowest daily volume weighted average price of the Common Stock in the fifteen (15) trading days prior to the conversion date (the “Conversion Price”), which Conversion Price is subject to adjustment for (i) stock splits, stock dividends, combinations, or similar events and (ii) full ratchet anti-dilution protection. The Company accounts for debt discount according to ASC 470-20
Debt With Conversion And Other Options
. Debt discount in the amount of $2,243,000 associated with the
Convertible Note
was recorded and will be amortized over the term of the note. Upon certain events of default, the conversion price of the Note will automatically become 70% of the average of the three (3) lowest volume weighted average prices of the Common Stock in the twenty (20) consecutive trading days prior to the conversion date for so long as such event of default remains in effect. All interest payments under the Note are payable, at the Company’s option, in cash or shares of Common Stock.
In addition, at any time that (i) the daily volume weighted average price of the Common Stock for the prior ten (10) consecutive trading days is $0.70 or more and (ii) the average daily trading value of the Common Stock is greater than $2,500,000 for the prior ten (10) consecutive trading days, then the Company may demand, upon one (1) day’s notice, that the holder convert the Note at the Conversion Price.
The Company may prepay in cash any portion of the outstanding principal amount of the Note and any accrued and unpaid interest by, upon ten (10) days’ written notice to the holder, paying an amount equal to (i) 110% of the sum of the then-outstanding principal amount of the Note plus accrued but unpaid interest, if the prepayment date is within 90 days of the issuance date of the Note; (ii) 115% of the sum of the then-outstanding principal amount of the Note plus accrued but unpaid interest, if the prepayment date is between 91 days and 180 days of the issuance date of the Note; or (iii) 125% of the sum of the then-outstanding principal amount of the Note plus accrued but unpaid interest, if the prepayment date is after 180 days of the issuance date of the Note.
NOTE 9 – CONTINGENT CONSIDERATION LIABILITY
The Company accounts for “contingent consideration” according to FASB ASC 805,
“Business Combinations”
(“FASB ASC 805”). Contingent consideration typically represents the acquirer’s obligation to transfer additional assets or equity interests to the former owners of the acquiree if specified future events occur or conditions are met. FASB ASC 805 requires that contingent consideration be recognized at the acquisition-date fair value as part of the consideration transferred in the transaction.
In the acquisition of Black Oak Gallery, the Company valued the contingent consideration based on an analysis using a cash flow model to determine the expected contingent consideration payment, which model determined that the aggregate expected contingent consideration liability was $15,305,463 and the present value of the contingent consideration liability was $12,754,553. Accordingly, the Company recognized at April 1, 2016, the closing date of the Black Oak merger, a $12,754,553 contingent consideration liability associated with the contingent consideration paid pursuant to the Merger Agreement.
On April 1, 2017, the anniversary date of the acquisition, as well as the settlement date of the contingent consideration, the final contingent consideration was $16,434,620, or approximately $1.1 million greater than the expected contingent consideration liability of $15,305,463 which the Company estimated on April 1, 2016, the closing date of the Black Oak acquisition.
At March 31, 2017 and December 31, 2016, the total contingent consideration based upon the analysis using the cash flow model to determine the expected contingent consideration payment was $16,434,620 and $12,085,858, respectively, a difference of approximately $4.3 million. The increase was primarily due to i.) revisions in the estimated probability that the upper threshold of $16,667,000 of the revenue target component of the contingent consideration would be met, which revenue target was met as of April 1, 2017, and ii.) the change in the quoted price of the underlying shares of the Company’s common stock which change affected the number of shares to be issued pursuant to the contingent consideration.
Changes in the fair market valuation of contingent consideration are recognized in the consolidated statements of operations. For the three months ended March 31, 2017, the change in the fair market valuation of contingent consideration was $4,348,761 which amount reflects the final settlement of the change in fair value of the Contingent Consideration liability.
See
“Note 10 – Fair Value Measurements”
for further information.
See
“Note 16 – Subsequent Events”
for further information on the final settlement of the contingent consideration liability during the month ended April 2017.
NOTE 10 – FAIR VALUE MEASUREMENTS
Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following tables set forth the financial liabilities measured at fair value on a recurring basis by level within the fair value hierarchy as of the dates indicated:
|
|
Fair Value at
March 31,
|
|
|
Fair Value Measurement Using
|
|
Description
|
|
2017
|
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative Liabilities – Conversion Feature
|
|
$
|
4,848,600
|
|
|
$
|
–
|
|
|
$
|
–
|
|
|
$
|
4,848,600
|
|
Liability – Contingent Consideration
|
|
|
16,434,620
|
|
|
|
–
|
|
|
|
–
|
|
|
|
16,434,620
|
|
|
|
$
|
21,283,220
|
|
|
$
|
–
|
|
|
$
|
–
|
|
|
$
|
21,283,220
|
|
|
|
Fair Value at December 31,
|
|
|
Fair Value Measurement Using
|
|
Description
|
|
2016
|
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative Liabilities – Conversion Feature
|
|
$
|
6,987,000
|
|
|
$
|
–
|
|
|
$
|
–
|
|
|
$
|
6,987,000
|
|
Liability – Contingent Consideration
|
|
|
12,085,859
|
|
|
|
–
|
|
|
|
–
|
|
|
|
12,085,859
|
|
|
|
$
|
19,072,859
|
|
|
$
|
–
|
|
|
$
|
–
|
|
|
$
|
19,072,859
|
|
No financial assets were measured on a recurring basis as of March 31, 2017 and December 31, 2016.
The following table presents a reconciliation of the derivative liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the three months ended March 31, 2017 and 2016:
Balance at December 31, 2016
|
|
$
|
6,987,000
|
|
|
|
|
|
|
Change in Fair Market Value of Conversion Feature
|
|
|
(1,610,750
|
)
|
Derivative Debt Converted into Equity
|
|
|
(2,770,650
|
)
|
Issuance of Debt Instruments with Derivatives
|
|
|
2,243,000
|
|
|
|
|
|
|
Balance at March 31, 2017
|
|
$
|
4,848,600
|
|
NOTE 10 – FAIR VALUE MEASUREMENTS
(Continued)
The following table presents a reconciliation of the Contingent Consideration liability measured at fair value on a recurring basis using significant unobservable inputs (Level 3) for the three months ended March 31, 2017:
Balance at December 31, 2016
|
|
$
|
12,085,859
|
|
|
|
|
|
|
Change in Fair Market Valuation of Contingent Consideration
|
|
|
4,348,761
|
|
|
|
|
|
|
Balance at March 31, 2017
|
|
$
|
16,434,620
|
|
Non-Financial Assets Measured at Fair Value on a Non-Recurring Basis
Non-financial assets, such as property, equipment and leasehold improvements, goodwill, and intangible assets, are required to be measured at fair value only when an impairment loss is recognized. The Company did not record an impairment charge related to these assets during the three months ended March 31, 2017 and 2016.
NOTE 11 – INCOME TAXES
For the three months ended March 31, 2017 and 2016, the Company had no income tax expense (benefit).
As of March 31, 2017 and December 31, 2016, the components of deferred income tax assets and deferred income tax liabilities consisted of the following:
|
|
March 31,
2017
|
|
|
December 31,
2016
|
|
|
|
|
|
|
|
|
Deferred Income Tax Assets:
|
|
|
|
|
|
|
Allowance for Bad Debt
|
|
$
|
–
|
|
|
$
|
–
|
|
Warrants Expense
|
|
|
4,523,171
|
|
|
|
4,186,000
|
|
Derivatives Expense
|
|
|
5,958,719
|
|
|
|
4,067,000
|
|
Net Operating Losses
|
|
|
16,763,194
|
|
|
|
15,242,000
|
|
|
|
|
|
|
|
|
|
|
Deferred Income Tax Liabilities:
|
|
|
|
|
|
|
|
|
Depreciation
|
|
|
(1,467,893
|
)
|
|
|
(1,334,000
|
)
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
25,777,191
|
|
|
|
22,161,000
|
|
Valuation Allowance
|
|
|
(25,777,191
|
)
|
|
|
(22,161,000
|
)
|
|
|
|
|
|
|
|
|
|
Net Deferred Tax Liabilities
|
|
$
|
–
|
|
|
$
|
–
|
|
For the three months ended March 31, 2017 and 2016, certain of the Company’s subsidiaries produced and sold cannabis or cannabis pure concentrates, subjecting the Company to the limits of IRC Section 280E. Pursuant to IRC Section 280E, the Company is allowed only to deduct expenses directly related to sales of product.
Permanent differences include ordinary and necessary business expenses deemed by the Company as a non-allowable deduction under IRC Section 280E, and tax deductions related to equity compensation that are less than the compensation recognized for financial reporting.
NOTE 11 – INCOME TAXES
(Continued)
As of March 31, 2017 and December 31, 2016, the Company had net operating loss carryforwards of approximately $37,885,008 and $34,940,000, respectively, which, if unused, will expire beginning in the year 2034. These tax attributes are subject to an annual limitation from equity shifts, which constitute a change of ownership as defined under Internal Revenue Code (“IRC”) Section 382, which will limit their utilization. The Company has yet to assess the effect of these limitations, but expects these losses to be substantially limited. Accordingly, the Company has placed a reserve against any assets associated with these losses.
The Company files income tax returns in the U.S. federal jurisdiction and various state and local jurisdictions. All tax years from 2012 to 2016 are subject to examination.
Management assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to use the existing deferred tax assets. A significant piece of objective negative evidence evaluated was the cumulative losses incurred through the period ended March 31, 2017. Such objective evidence limits the ability to consider other subjective evidence, such as our projections for future growth. On the basis of this evaluation, as of March 31, 2017, a valuation allowance has been recorded against all deferred tax assets as these assets are more likely than not to be unrealized. The amount of the deferred tax asset considered realizable, however, could be adjusted if estimates of future taxable income during the carryforward period are reduced or increased or if objective negative evidence in the form of cumulative losses is no longer present and additional weight may be given to subjective evidence such as our projections for growth.
NOTE 12 – EQUITY
Preferred Stock
Series A Preferred Stock is convertible on a one-for-one basis into common stock and has all of the voting rights of the Company’s common stock.
Each share of Series B Preferred Stock: (i) is entitled to 100 votes for each share of common stock into which a share of Series B Preferred Stock is convertible and (ii) is convertible, at the option of the holder, on a 1-for-5.384325537 basis, into shares of the Company’s common stock.
During the three months ended March 31, 2017, the Company issued 600,000 shares of Series B preferred stock for compensation in the amount of $1,035,406.
Common Stock
During the three months ended March 31, 2017, senior secured convertible promissory notes and accrued interest in the amount of $3,688,963 were converted into 16,281,088 shares of common stock.
During the three months ended March 31, 2017, the Company sold 6,185,395 shares of common stock for the net amount of $1,700,000 pursuant to an equity financing facility with an accredited investor.
During the three months ended March 31, 2017, the Company issued 125,000 shares of common stock for director fees in the amount of $37,500, issued 467,647 shares of common stock for services performed in the amount of $145,011 and issued 100,000 shares of common stock for compensation in the amount of $26,100.
During the three months ended March 31, 2016, senior secured convertible promissory notes and accrued interest in the amount of $961,740 were converted into 13,906,149 shares of common stock.
During the three months ended March 31, 2016, the Company sold 25,715,674 shares of common stock for the net amount of $3,208,134 pursuant to an equity financing facility with an accredited investor.
NOTE 12 – EQUITY
(Continued)
Stock-Based Compensation Expense
A summary of stock based compensation for the three months ended March 31, 2017 and 2016 is as follows:
|
|
March 31, 2017
|
|
|
March 31, 2016
|
|
Type of Award
|
|
Number of Shares or Options Granted
|
|
|
Stock-Based Compensation Expense
|
|
|
Number of Shares or Options Granted
|
|
|
Stock-Based Compensation Expense
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Options
|
|
|
–
|
|
|
$
|
47,589
|
|
|
|
6,700,000
|
|
|
$
|
47,589
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Grants:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employees (Common Stock)
|
|
|
100,000
|
|
|
|
26,100
|
|
|
|
–
|
|
|
|
–
|
|
Employees (Series B Preferred Stock)
|
|
|
600,000
|
|
|
|
1,035,406
|
|
|
|
–
|
|
|
|
–
|
|
Directors (Common Stock)
|
|
|
125,000
|
|
|
|
37,500
|
|
|
|
350,000
|
|
|
|
60,550
|
|
Non-Employee Consultants (Common Stock)
|
|
|
467,647
|
|
|
|
145,011
|
|
|
|
–
|
|
|
|
–
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Stock-Based Compensation Expense
|
|
|
1,292,647
|
|
|
$
|
1,291,606
|
|
|
|
7,050,000
|
|
|
$
|
108,139
|
|
NOTE 13 – OPERATING LEASE COMMITMENTS
The Company leases certain business facilities under operating lease agreements that specify minimum rentals. Many of these have renewal provisions. The Company’s net rent expense for the three months ended March 31, 2017 and 2016 was $314,813 and $133,867, respectively.
NOTE 14 – SEGMENT INFORMATION
The Company’s operating and reportable segments are currently organized around the following products that it offers as part of its core business strategy:
|
·
|
Herbs and Produce Products – Includes herbs and leafy greens that are grown using classic Dutch hydroponic farming methods.
|
|
|
|
|
·
|
Cannabis Dispensary, Cultivation and Production – Includes cannabis-focused retail, cultivation and production
|
These two reportable segments, which are described in greater detail below, had previously been reported on a combined basis as they had been operated and evaluated as one operating segment. The Company experienced significant growth over the last year in most of our product areas. As the Company has grown organically, and as the Company previously added to its capabilities through acquisitions, its products have increased in scale and become more strategically important and distinctly organized and managed under these two groupings. In addition, Derek Peterson, the Company’s Chief Operating Decision Maker (“CODM”), has begun reviewing results and managing and allocating resources between these two strategic business groupings, and has begun budgeting using these business segments. The Company’s CODM reviews revenues including intersegment revenues, gross profit and operating income (loss) before income taxes when evaluating segment performance and allocating resources to each segment. Accordingly, intersegment revenue is included in the segment revenues presented in the tables below and is eliminated from revenues and cost of sales in the “Eliminations and Other” column. The “Eliminations and Other” column also includes various income and expense items that the Company does not allocate to its operating segments. These income and expense amounts include the results of the Company’s hydroponic equipment, which are not material, interest income, interest expense, corporate overhead, and corporate-wide expense items such as legal and professional fees as well as expense items for which we have not identified a reasonable basis for allocation. The accounting policies of the reportable segments are the same as those described in Note 2 of the Notes to the Consolidated Financial Statements.
NOTE 14 – SEGMENT INFORMATION
(Continued)
Herbs and Produce Products
Either independently or in conjunction with third parties, we are a retail seller of locally grown hydroponic herbs, produce, and floral products, which are distributed through major grocery stores throughout the East and Midwest regions of the U.S.
Cannabis Dispensary, Cultivation and Production
Either independently or in conjunction with third parties, we operate medical marijuana retail dispensaries, medical marijuana cultivation and production facilities in California and Nevada. We own real property in Nevada on which we plan to build a medical marijuana dispensary. All of our retail dispensaries in California and Nevada offer a broad selection of medical cannabis products including flowers, concentrates and edibles. We also produce and sell a line of medical cannabis flowers, as well as a line of medical cannabis-extracted products, which include concentrates, cartridges, vape pens and wax products.
Summarized financial information concerning the Company’s reportable segments is shown in the following tables. Total asset amounts at March 31, 2017 and 2016, exclude intercompany receivable balances eliminated in consolidation.
|
|
Three Months Ended March 31, 2017
|
|
|
|
Herbs and
Produce
Products
|
|
|
Cannabis Dispensary, Cultivation and Production
|
|
|
Eliminations
and Other
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Revenues
|
|
$
|
917,143
|
|
|
$
|
5,887,038
|
|
|
$
|
20,275
|
|
|
$
|
6,824,456
|
|
Cost of Goods Sold
|
|
|
969,815
|
|
|
|
5,495,578
|
|
|
|
-
|
|
|
|
6,465,393
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross Profit
|
|
|
(52,672
|
)
|
|
|
391,460
|
|
|
|
20,275
|
|
|
|
359,063
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, General and Administrative Expenses
|
|
|
659,063
|
|
|
|
2,627,005
|
|
|
|
3,100,232
|
|
|
|
6,386,300
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss from Operations
|
|
|
(711,735
|
)
|
|
|
(2,235,545
|
)
|
|
|
(3,079,957
|
)
|
|
|
(6,027,237
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Expense:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of Debt Discount
|
|
|
-
|
|
|
|
-
|
|
|
|
(610,616
|
)
|
|
|
(610,616
|
)
|
Loss on Extinguishment of Debt
|
|
|
-
|
|
|
|
-
|
|
|
|
(1,039,458
|
)
|
|
|
(1,039,458
|
)
|
Loss on Fair Market Valuation of Derivatives
|
|
|
-
|
|
|
|
-
|
|
|
|
1,610,750
|
|
|
|
1,610,750
|
|
Interest Income (Expense)
|
|
|
-
|
|
|
|
-
|
|
|
|
(157,833
|
)
|
|
|
(157,833
|
)
|
Loss on Fair Market Valuation of Contingent Consideration
|
|
|
-
|
|
|
|
(4,348,761
|
)
|
|
|
-
|
|
|
|
(4,348,761
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Other Expense
|
|
|
-
|
|
|
|
(4,348,761
|
)
|
|
|
(197,157
|
)
|
|
|
(4,545,918
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss Before Provision for Income Taxes
|
|
$
|
(711,735
|
)
|
|
$
|
(6,584,306
|
)
|
|
$
|
(3,277,114
|
)
|
|
$
|
(10,573,155
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Assets at March 31, 2017
|
|
$
|
7,133,499
|
|
|
$
|
59,367,012
|
|
|
$
|
11,077,191
|
|
|
$
|
77,572,702
|
|
NOTE 14 – SEGMENT INFORMATION
(Continued)
|
|
Three Months Ended March 31, 2016
|
|
|
|
Herbs and
Produce
Products
|
|
|
Cannabis Dispensary, Cultivation and Production
|
|
|
Eliminations
and
Other
|
|
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Revenues
|
|
$
|
1,401,443
|
|
|
$
|
130,203
|
|
|
$
|
16,521
|
|
|
$
|
1,548,167
|
|
Cost of Goods Sold
|
|
|
1,200,932
|
|
|
|
213,261
|
|
|
|
–
|
|
|
|
1,414,193
|
|
Gross Profit
|
|
|
200,511
|
|
|
|
(83,058
|
)
|
|
|
16,521
|
|
|
|
133,974
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, General and Administrative Expenses
|
|
|
518,652
|
|
|
|
202,136
|
|
|
|
1,325,560
|
|
|
|
2,046,348
|
|
Loss from Operations
|
|
|
(318,141
|
)
|
|
|
(285,194
|
)
|
|
|
(1,309,039
|
)
|
|
|
(1,912,374
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Expense:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of Debt Discount
|
|
|
-
|
|
|
|
-
|
|
|
|
(94,406
|
)
|
|
|
(94,406
|
)
|
Loss on Extinguishment of Debt
|
|
|
-
|
|
|
|
-
|
|
|
|
(920,797
|
)
|
|
|
(920,797
|
)
|
Gain on Fair Market Valuation of Derivatives
|
|
|
-
|
|
|
|
-
|
|
|
|
(1,160,700
|
|
|
|
(1,160,700
|
)
|
Interest Expense
|
|
|
-
|
|
|
|
-
|
|
|
|
(55,995
|
)
|
|
|
(55,995
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Other Expense
|
|
|
-
|
|
|
|
-
|
|
|
|
(2,231,898
|
)
|
|
|
(2,231,898
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss Before Provision for Income Taxes
|
|
$
|
(318,141
|
)
|
|
$
|
(285,194
|
)
|
|
$
|
(3,540,937
|
)
|
|
$
|
(4,144,272
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Assets at March 31, 2016
|
|
$
|
6,667,866
|
|
|
$
|
2,734,868
|
|
|
$
|
2,750,386
|
|
|
$
|
12,153,120
|
|
NOTE 15 – LITIGATION AND CLAIMS
The Company is the subject of lawsuits and claims arising in the ordinary course of business from time to time. The Company reviews any such legal proceedings and claims on an ongoing basis and follows appropriate accounting guidance when making accrual and disclosure decisions. The Company establishes accruals for those contingencies where the incurrence of a loss is probable and can be reasonably estimated, and it discloses the amount accrued and the amount of a reasonably possible loss in excess of the amount accrued, if such disclosure is necessary for the Company’s financial statements to not be misleading. To estimate whether a loss contingency should be accrued by a charge to income, the Company evaluates, among other factors, the degree of probability of an unfavorable outcome and the ability to make a reasonable estimate of the amount of the loss. The Company does not record liabilities when the likelihood that the liability has been incurred is probable, but the amount cannot be reasonably estimated. Based upon present information, the Company determined that there were no matters that required an accrual as of March 31, 2017, nor were there any asserted or unasserted material claims for which material losses are reasonably possible.
NOTE 16 – SUBSEQUENT EVENTS
Put on Equity Financing Facility
In the second quarter of 2017, the Company sold 3,689,701 shares of common stock for the net amount of $750,000 pursuant to an equity financing facility with an accredited investor.
Debt and Interest Converted into Equity
During the second quarter of 2017, senior secured convertible promissory notes and accrued interest in the amount of $1,267,537 was converted into 6,060,886 shares of common stock.
Black Oak Gallery Contingent Consideration Liability
Subsequent to the quarter ended March 31, 2017, the Company is required to release from escrow common stock equivalent of approximately 18,090,000 shares of its common stock and make a cash payment of $2,088,000 in connection with the Black Oak Gallery acquisition and the associated contingent consideration liability. Common stock equivalent of approximately 32,336,000 shares were clawed-back pursuant to the appreciation of the quoted price of the Company’s stock underlying the market-based component of the contingent consideration.